999
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Single Agent Vinflunine in the Salvage Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Trial of the Sarah Cannon Research Consortium

, , , , , , , & show all
Pages 275-279 | Published online: 26 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabio AB Schutz, Joaquim Bellmunt, Jonathan E Rosenberg & Toni K Choueiri. (2011) Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid. Expert Opinion on Drug Safety 10:4, pages 645-653.
Read now

Articles from other publishers (5)

Kianna Robinson & Venkataswarup Tiriveedhi. (2020) Perplexing Role of P-Glycoprotein in Tumor Microenvironment. Frontiers in Oncology 10.
Crossref
Brandon Bumbaca & Wei Li. (2018) Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies. Acta Pharmaceutica Sinica B 8:4, pages 518-529.
Crossref
Larissa Siqueira Penna, João Antonio Pêgas Henriques & Diego Bonatto. (2017) Anti-mitotic agents: Are they emerging molecules for cancer treatment?. Pharmacology & Therapeutics 173, pages 67-82.
Crossref
Holger Gerullis, Friedhelm Wawroschek, Claus-Henning Köhne & Thorsten Holger Ecke. (2016) Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience. Therapeutic Advances in Urology 9:1, pages 28-35.
Crossref
. (2011) Current World Literature. Current Opinion in Urology 21:3, pages 257-264.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.